Show simple item record

dc.contributor.advisorMoungi Bawendi.en_US
dc.contributor.authorWong, Cliff R. (Cliff Richard)en_US
dc.contributor.otherMassachusetts Institute of Technology. Dept. of Chemistry.en_US
dc.date.accessioned2011-05-23T18:11:19Z
dc.date.available2011-05-23T18:11:19Z
dc.date.copyright2011en_US
dc.date.issued2011en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/63062
dc.descriptionThesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemistry, 2011.en_US
dc.descriptionCataloged from PDF version of thesis.en_US
dc.descriptionIncludes bibliographical references.en_US
dc.description.abstractAssembly of functional nanocomponents offers promising applications in drug delivery to solid tumors and bottom-up synthesis and integration of nanodevices. This thesis presents a novel multistage nanoparticle delivery system consisting of an assembly of nanoparticles that can change its size to facilitate transport into solid tumors. Current FDA-approved nanotherapeutics, which function based on the enhanced permeation and retention (EPR) effect, suffer from poor penetration into the extravascular regions of the tumor due to the dense collagen matrix, resulting in heterogeneous therapeutic effects and likely contributing to tumor regression and development of resistance. We propose a multistage nanoparticle system that "shrinks" when it extravasates into the tumor and is exposed to the tumor microenvironment, allowing enhanced penetration into the tumor parenchyma. This "shrinkage" is preferentially triggered in the tumor through cleavage by MMPs, proteases highly expressed in the tumor microenvironment. A multistage nanoparticle system allows us to engineer the size and surface properties of each stage independently for preferential transvascular transport into tumors and high diffusion in the tumor's interstitial space. To our knowledge, this work is the first demonstration of a size-changing nanoparticle delivery system in vivo. Multistage nanoparticle delivery systems provide a promising approach to improving the delivery of anticancer agents into solid tumors and as a result the enhancement of the drug's therapeutic efficacy. Another area that necessitates the controlled assembly of nanocomponents is in the integration of nanodevices and nanocircuitry. We have developed a method of combining the synthesis and assembly of semiconducting nanowires in a single step using electrically controlled catalytic nanowire growth. Our results demonstrate electric field-modulated nanowire growth that can be used as a simple and inexpensive method for fabricating and integrating nanoscale devices.en_US
dc.description.statementofresponsibilityby Cliff R. Wong.en_US
dc.format.extent137 p.en_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsM.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectChemistry.en_US
dc.titleMultistage nanoparticle delivery system for deep penetration into solid tumor and electrically controlled catalytic nanowire growthen_US
dc.typeThesisen_US
dc.description.degreePh.D.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistry
dc.identifier.oclc724758971en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record